Event Description
Topic
2, 4-Dinitrophenol (DNP) as a Treatment for
Neuromuscular and Neurodegenerative Disease
Presented By
John Geisler, PhD, chief scientific officer, Mitochon Pharmaceuticals, Inc.
Target Audience
Physicians, nurse practitioners, nursing personnel, fellows, residents, medical students and other health care professionals who take care of children
Disclosure
Speakers and all others who have the ability to control the content of continuing medical education activities sponsored by St. Christopher’s Hospital for Children are expected to disclose to the audience whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s).
Additional Information
Continental breakfast is available at 7:30 a.m. outside DiGeorge Center. Parking passes for visiting physicians are available. |